Search through
4-(Methylamino)-3-nitrobenzoic acid (CAS 41263-74-5) serves as a critical building block in the API intermediates market, primarily utilized for the synthesis of benzimidazole derivatives like Dabigatran, where a Pharma/API purity of 99% is mandatory to ensure safety and efficacy. 4-Methylamino-3-nitro-benzoic acid is increasingly sourced through specialized custom synthesis services in the United States as domestic CDMO growth prioritizes supply chain resilience and strict adherence to FDA-regulated quality standards. 3-Nitro-4-methylaminobenzoic acid has become a high-priority requirement for any US-based bulk chemical supplier catering to the biopharmaceutical sector, reflecting a strategic shift toward high purity fine chemicals that minimize impurity carry-over in complex therapeutic formulations. We are an established 4-(Methylamino)-3-nitrobenzoic acid intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting 4-(Methylamino)-3-nitrobenzoic acid COA/TDS/SDS region-specific regulatory support. reliable lead times, worldwide supply chain capabilities
4-(Methylamino)-3-nitrobenzoic acid (CAS 41263-74-5) serves as a critical building block in the API intermediates market, primarily utilized for the synthesis of benzimidazole derivatives like Dabigatran, where a Pharma/API purity of 99% is mandatory to ensure safety and efficacy. 4-Methylamino-3-nitro-benzoic acid is increasingly sourced through specialized custom synthesis services in the United States as domestic CDMO growth prioritizes supply chain resilience and strict adherence to FDA-regulated quality standards. 3-Nitro-4-methylaminobenzoic acid has become a high-priority requirement for any US-based bulk chemical supplier catering to the biopharmaceutical sector, reflecting a strateg...
.3d8f8f41.svg)
Industrial Chemicals
.3556d45a.svg)
Pharmaceutical Actives & Precursors
Intermediates & Precursors
.7767eb0f.png)
Chemical Properties & Specifications
P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501
Skin Irrit. 2 (100%)
Eye Irrit. 2 (100%)
4-(Methylamino)-3-nitrobenzoic acid is a key building block and intermediate used in the synthesis of Dabigatran etexilate, an anticoagulant medication, and other triazole or benzimidazole derivatives
The compound serves as a versatile organic building block in the production of complex molecules for the pharmaceutical and fragrance industries, where its nitro and methylamino groups allow for precise chemical transformations
It is utilized in laboratory settings for the development of novel therapeutics targeting conditions such as diabetes, hypertension, dementia, schizophrenia, and autoimmune diseases.
4-(Methylamino)-3-nitrobenzoic acid is a chemical compound used primarily as a key pharmaceutical intermediate, most notably in the synthesis of the anticoagulant drug dabigatran, as well as in the production of dyes and other organic compounds
This compound is widely used in the pharmaceutical, dye manufacturing, and biotechnology industries, and is also utilized in chemical research and materials science
It is compatible with organic solvents such as DMSO and methanol and is typically handled as a yellow crystalline powder or solid for use in organic synthesis
Standard specifications include CAS number 41263-74-5, molecular weight 196.16, purity typically ≥98%, and documentation such as COA, TDS, impurity reports, and regulatory compliance documents
Scimplify has capabilities for global distribution and custom synthesis through an integrated network of manufacturers and logistics partners with reliable lead time
The product is export ready with a standard MOQ starting from 100 kgs, with lead times for international customers depending on the shipping destination and specific grade.
